Literature DB >> 20597086

ROR1 expression is not a unique marker of CLL.

Gábor Barna1, Rudolf Mihalik, Botond Timár, Judit Tömböl, Zsolt Csende, Anna Sebestyén, Csaba Bödör, Balázs Csernus, Lilla Reiniger, István Peták, András Matolcsy.   

Abstract

Recent studies have identified receptor tyrosine kinase-like orphan receptor 1 (ROR1) on the surface of chronic lymphoid leukaemia (CLL) cells. In order to determine whether ROR1 expression is a suitable surrogate marker for the diagnosis of CLL we analysed the mRNA level of ROR1 in different types of non-Hodgkin lymphomas (NHL), and detected elevated levels of ROR1 compared to control peripheral mononuclear cells in several entities (CLL ≥ mantle cell lymphoma (MCL) > marginal zone lymphoma (MZL) >> diffuse large B-cell lymphoma > follicular lymphoma). ROR1 protein was expressed intensely on the cell surface of lymphoma cells with leukaemic blood count detected by three colour immunofluorescence. Our results indicate that ROR1 expression is not limited to CLL cases, but it is more prevalent in NHLs, mainly in MCL where it is expressed intensely and MZL where it is expressed moderately, suggesting a general role of ROR1 in lymphoma genesis and/or maintenance.
Copyright © 2010 John Wiley & Sons, Ltd. Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20597086     DOI: 10.1002/hon.948

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  29 in total

Review 1.  The role of Ryk and Ror receptor tyrosine kinases in Wnt signal transduction.

Authors:  Jennifer Green; Roel Nusse; Renée van Amerongen
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-02-01       Impact factor: 10.005

2.  ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo.

Authors:  Rajeswaran Mani; Chi-Ling Chiang; Frank W Frissora; Ribai Yan; Xiaokui Mo; Sivasubramanian Baskar; Christoph Rader; Rebecca Klisovic; Mitch A Phelps; Ching-Shih Chen; Robert J Lee; John C Byrd; Robert Baiocchi; L James Lee; Natarajan Muthusamy
Journal:  Exp Hematol       Date:  2015-04-29       Impact factor: 3.084

3.  Differential and tumor-specific expression of CD160 in B-cell malignancies.

Authors:  Timothy W Farren; Jerome Giustiniani; Feng-Ting Liu; Dimitris A Tsitsikas; Marion G Macey; James D Cavenagh; Heather E Oakervee; David Taussig; Adrian C Newland; Maria Calaminici; Armand Bensussan; Michael Jenner; John G Gribben; Samir G Agrawal
Journal:  Blood       Date:  2011-06-28       Impact factor: 22.113

4.  Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1.

Authors:  Junpeng Qi; Xiuling Li; Haiyong Peng; Erika M Cook; Eman L Dadashian; Adrian Wiestner; HaJeung Park; Christoph Rader
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

5.  Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma.

Authors:  Hanna Karvonen; David Chiron; Wilhelmiina Niininen; Sara Ek; Mats Jerkeman; Elaheh Moradi; Matti Nykter; Caroline A Heckman; Olli Kallioniemi; Astrid Murumägi; Daniela Ungureanu
Journal:  Blood Adv       Date:  2017-11-09

6.  Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.

Authors:  Suping Zhang; Bing Cui; Hsien Lai; Grace Liu; Emanuela M Ghia; George F Widhopf; Zhuhong Zhang; Christina C N Wu; Liguang Chen; Rongrong Wu; Richard Schwab; Dennis A Carson; Thomas J Kipps
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-19       Impact factor: 11.205

Review 7.  Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.

Authors:  Pavlína Janovská; Vítězslav Bryja
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

8.  The onco-embryonic antigen ROR1 is expressed by a variety of human cancers.

Authors:  Suping Zhang; Liguang Chen; Jessica Wang-Rodriguez; Ling Zhang; Bing Cui; Wendy Frankel; Rongrong Wu; Thomas J Kipps
Journal:  Am J Pathol       Date:  2012-10-04       Impact factor: 4.307

9.  ROR1 can interact with TCL1 and enhance leukemogenesis in Eμ-TCL1 transgenic mice.

Authors:  George F Widhopf; Bing Cui; Emanuela M Ghia; Liguang Chen; Karen Messer; Zhouxin Shen; Steven P Briggs; Carlo M Croce; Thomas J Kipps
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

10.  CAR T cells Targeting Human Immunoglobulin Light Chains Eradicate Mature B-cell Malignancies While Sparing a Subset of Normal B Cells.

Authors:  Raghuveer Ranganathan; Peishun Shou; Sarah Ahn; Chuang Sun; John West; Barbara Savoldo; Gianpietro Dotti
Journal:  Clin Cancer Res       Date:  2021-04-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.